All stock lists
Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
Healthcare · Medical Care Facilities
39.10-0.34 (-0.86%)
Insider Score
––Not scored
GRDN Insider Score
Insiders here have filed 17 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
GRDN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 351.77 M | 336.60 M | 397.62 M | 377.43 M | 344.33 M | 329.31 M |
| Revenue Growth (YoY) | 2.16 % | 2.21 % | 17.44 % | 20.05 % | 14.76 % | 19.57 % |
| Cost of Revenue | 271.72 M | 260.29 M | 312.11 M | 302.71 M | 276.19 M | 264.96 M |
| Gross Profit | 80.04 M | 76.31 M | 85.50 M | 74.72 M | 68.15 M | 64.35 M |
| SG&A Expense | 59.40 M | 58.63 M | 48.91 M | 57.89 M | 55.57 M | 51.34 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 59.40 M | 58.63 M | 48.91 M | 57.89 M | 55.57 M | 51.34 M |
| Operating Income | 20.64 M | 17.68 M | 36.60 M | 16.83 M | 12.58 M | 13.01 M |
| Pretax Income | 29.79 M | 18.29 M | 31.10 M | 16.63 M | 12.59 M | 13.11 M |
| Tax Provision | 7.67 M | 4.75 M | 9.83 M | 7.04 M | 3.76 M | 3.83 M |
| Net Income | 21.87 M | 13.29 M | 20.92 M | 9.82 M | 9.03 M | 9.45 M |
| EPS (Basic) | 0.35 | 0.21 | 0.33 | 0.16 | 0.15 | 0.15 |
| EPS (Diluted) | 0.34 | 0.21 | 0.33 | 0.15 | 0.14 | 0.15 |
| Shares Outstanding | 63.33 M | 63.32 M | 63.32 M | 62.12 M | 62.05 M | 62.04 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.